(Q79536278)

English

Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody)

scientific article published on 11 January 2007

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17215854%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

Treatment of severe refractory autoimmune hemolytic anemia in B-cell chronic lymphocytic leukemia with alemtuzumab (humanized CD52 monoclonal antibody) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17215854%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

autoimmune hemolytic anemia

1 reference

based on heuristic

inferred from title

B-cell chronic lymphocytic leukemia

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17215854%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

author name string

C Karlsson

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17215854%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

F Celsing

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17215854%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

J Lundin

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17215854%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

publication date

11 January 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17215854%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17215854%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

21

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17215854%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17215854%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

511-514

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17215854%20AND%20SRC:MED&resulttype=core&format=json

24 December 2019

The prognostic role of metastatic pattern in colorectal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404512

7 January 2021

based on heuristic

inferred from DOI database lookup

Hemolytic anemia after fludarabine therapy for chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404512

7 January 2021

based on heuristic

inferred from DOI database lookup

Monoclonal antibodies in the treatment of autoimmune cytopenias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404512

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404512

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II trial of subcutaneous anti-CD52 monoclonal antibody alemtuzumab (Campath-1H) as first-line treatment for patients with B-cell chronic lymphocytic leukemia (B-CLL).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404512

7 January 2021

based on heuristic

inferred from DOI database lookup

Humanized CD52 monoclonal antibody campath-1H as first-line treatment in chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404512

7 January 2021

based on heuristic

inferred from DOI database lookup

Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404512

7 January 2021

based on heuristic

inferred from DOI database lookup

Cellular immune reconstitution after subcutaneous alemtuzumab (anti-CD52 monoclonal antibody, CAMPATH-1H) treatment as first-line therapy for B-cell chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404512

7 January 2021

based on heuristic

inferred from DOI database lookup

Alemtuzumab therapy for severe autoimmune hemolysis in a patient with B-cell chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404512

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab for Immune Cytopenia in Adults: Idiopathic Thrombocytopenic Purpura, Autoimmune Hemolytic Anemia, and Evans Syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404512

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab-based chemotherapy for steroid-refractory autoimmune hemolytic anemia of chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404512

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of treatment with Campath-1H in patients with autoimmune cytopenias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404512

7 January 2021

based on heuristic

inferred from DOI database lookup

CAMPATH-1H in the treatment of autoimmune cytopenias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404512

7 January 2021

based on heuristic

inferred from DOI database lookup

Remission of pure red cell aplasia in T-cell receptor gammadelta-large granular lymphocyte leukemia after therapy with low-dose alemtuzumab

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404512

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of pure red cell aplasia and autoimmune haemolytic anaemia in chronic lymphocytic leukaemia with Campath-1H.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404512

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79536278&oldid=2220734575"